Goldfinch Bio compound targets TRPC5 for the treatment of focal segmental glomerulosclerosis Nov. 6, 2018
Exome sequencing reveals SLC20A1 to be a possible cause of cloacal and bladder exstrophy Oct. 25, 2018
Xortx's pre-IND meeting with FDA identifies accelerated clinical development plan for XRx-008 Oct. 24, 2018
RSS